BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21705622)

  • 21. Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis.
    Rhee L; Murphy SF; Kolodziej LE; Grimm WA; Weber CR; Lodolce JP; Chang JE; Bartulis SJ; Messer JS; Schneider JR; Paski S; Nero TM; Boone DL
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(2):G220-7. PubMed ID: 22595989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The function of Sphingosine-1-phosphate receptor 2 (S1PR2) in maintaining intestinal barrier and inducing ulcerative colitis.
    Chen T; Gu K; Lin R; Liu Y; Shan Y
    Bioengineered; 2022 May; 13(5):13703-13717. PubMed ID: 35707833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model.
    Woo JK; Choi S; Kang JH; Kim DE; Hurh BS; Jeon JE; Kim SY; Oh SH
    BMC Complement Altern Med; 2016 Dec; 16(1):498. PubMed ID: 27912750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice.
    Xue X; Ramakrishnan S; Anderson E; Taylor M; Zimmermann EM; Spence JR; Huang S; Greenson JK; Shah YM
    Gastroenterology; 2013 Oct; 145(4):831-41. PubMed ID: 23860500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency of microRNA-10b promotes DSS-induced inflammatory response via impairing intestinal barrier function.
    Zhao K; Wang C; Liu Y; Li Y; Hui T; Wang G; Zhang X; Xue X; Kang J; Feng G
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 2):48-54. PubMed ID: 36343490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porcine β-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis.
    Han F; Zhang H; Xia X; Xiong H; Song D; Zong X; Wang Y
    J Immunol; 2015 Feb; 194(4):1882-93. PubMed ID: 25601921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FoxO1 regulates TLR4/MyD88/MD2-NF-κB inflammatory signalling in mucosal barrier injury of inflammatory bowel disease.
    Han C; Guo L; Sheng Y; Yang Y; Wang J; Gu Y; Li W; Zhou X; Jiao Q
    J Cell Mol Med; 2020 Mar; 24(6):3712-3723. PubMed ID: 32057181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isosteviol attenuates DSS-induced colitis by maintaining intestinal barrier function through PDK1/AKT/NF-κB signaling pathway.
    Yao L; Chen X; Shen M; Zhao Y; Cao Q
    Int Immunopharmacol; 2023 Jan; 114():109532. PubMed ID: 36508925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis.
    Kathiria AS; Butcher MA; Hansen JM; Theiss AL
    Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(10):G885-96. PubMed ID: 23494124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.
    Vetrano S; Rescigno M; Cera MR; Correale C; Rumio C; Doni A; Fantini M; Sturm A; Borroni E; Repici A; Locati M; Malesci A; Dejana E; Danese S
    Gastroenterology; 2008 Jul; 135(1):173-84. PubMed ID: 18514073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.
    Cheng Y; Hall TR; Xu X; Yung I; Souza D; Zheng J; Schiele F; Hoffmann M; Mbow ML; Garnett JP; Li J
    EBioMedicine; 2022 Jan; 75():103758. PubMed ID: 34933179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
    Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
    Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
    Gadaleta RM; van Erpecum KJ; Oldenburg B; Willemsen EC; Renooij W; Murzilli S; Klomp LW; Siersema PD; Schipper ME; Danese S; Penna G; Laverny G; Adorini L; Moschetta A; van Mil SW
    Gut; 2011 Apr; 60(4):463-72. PubMed ID: 21242261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
    Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
    PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct roles of intracellular heat shock protein 70 in maintaining gastrointestinal homeostasis.
    Wang Y; Lin F; Zhu X; Leone VA; Dalal S; Tao Y; Messer JS; Chang EB
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G164-G178. PubMed ID: 29051186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spermidine protects intestinal mucosal barrier function in mice colitis via the AhR/Nrf2 and AhR/STAT3 signaling pathways.
    Yan B; Mao X; Hu S; Wang S; Liu X; Sun J
    Int Immunopharmacol; 2023 Jun; 119():110166. PubMed ID: 37104918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis.
    Darsigny M; St-Jean S; Boudreau F
    Inflamm Bowel Dis; 2010 Oct; 16(10):1739-50. PubMed ID: 20848487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice.
    Salaga M; Bartoszek A; Binienda A; Krajewska JB; Fabisiak A; Mosińska P; Dziedziczak K; Niewinna K; Talar M; Tarasiuk A; Kordek R; Fichna J
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.